Stockholders approve charter amendment to limit officer liability; elect three Class II directors

PLIANT THERAPEUTICS, INC.

Amendment limiting officer liability approved with 35.2M For, 3.8M Against, 881.7K Abstain; filed June 9, 2025.
Class II directors elected: John Curnutte (34.5M For), Katharine Knobil (26.7M For), Thomas McCourt (31.6M For).
Advisory say-on-pay passed with 30.0M For, 8.9M Against, 910.9K Abstain.
Ratification of Deloitte as auditor for FY2025 approved with 50.8M For, 506K Against, 931K Abstain.
Broker non-votes totaled 12.35M shares on all proposals except auditor ratification.

item 5.03item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.